Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer

Background/Aim: There is a strong association between malignancy and histone deacetylases (HDACs). Histone deacetylase inhibitors (HDACIs) are now being tested as antitumor agents in various clinical trials. We aimed to assess the clinical importance of HDAC-2 in breast cancer (BC). Materials and Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Garmpis, Nikolaos, Damaskos, Christos, Dimitroulis, Dimitrios, Kouraklis, Gregory, Garmpi, Anna, Sarantis, Panagiotis, Koustas, Evangelos, Patsouras, Alexandros, Psilopatis, Iason, Antoniou, Efstathios A., Karamouzis, Michail V., Kontzoglou, Konstantinos, Nonni, Afroditi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604828/
https://www.ncbi.nlm.nih.gov/pubmed/36294811
http://dx.doi.org/10.3390/jpm12101672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604828/
https://www.ncbi.nlm.nih.gov/pubmed/36294811
http://dx.doi.org/10.3390/jpm12101672

Ejemplares similares